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UbiquitinationCyclins are regulatory subunits that bind to and activate catalytic Cdks. Cyclin E associates with Cdk2 to
mediate the G1/S transition of the cell cycle. Cyclin E is overexpressed in breast, lung, skin, gastrointestinal,
cervical, and ovarian cancers. Its overexpression correlates with poor patient prognosis and is involved in the
etiology of breast cancer. We have been studying how cyclin E is normally downregulated during
development in order to determine if disruption of similar mechanisms could either contribute to its
overexpression in cancer, or be exploited to decrease its expression. In Xenopus laevis embryos, cyclin E
protein level is high and constant until its abrupt destabilization by an undeﬁned mechanism after the 12th
cell cycle, which corresponds to the midblastula transition (MBT) and remodeling of the embryonic to the
adult cell cycle. Since degradation of mammalian cyclin E is regulated by the ubiquitin proteasome system and
is phosphorylation dependent, we examined the role of phosphorylation in Xenopus cyclin E turnover. We
show that similarly to human cyclin E, phosphorylation of serine 398 and threonine 394 plays a role in cyclin E
turnover at the MBT. Immunoﬂuorescence analysis shows that cyclin E relocalizes from the cytoplasm to the
nucleus preceding its degradation. When nuclear import is inhibited, cyclin E stability is markedly increased
after the MBT. To investigate whether degradation of Xenopus cyclin E is mediated by the proteasomal
pathway, we used proteasome inhibitors and observed a progressive accumulation of cyclin E in the
cytoplasm after the MBT. Ubiquitination of cyclin E precedes its proteasomal degradation at the MBT. These
results show that cyclin E destruction at theMBT requires both phosphorylation and nuclear import, as well as
proteasomal activity.exico HSC, Cell Biology and
lbuquerque, NM 87131-0001,
y).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Oscillations of cyclin E–Cdk2 activity regulate the G1/S phase
transition of the metazoan cell cycle. The E-type cyclins (E1 and E2)
function by integrating external growth stimuli to promote cell
proliferation (Ekholm and Reed, 2001). In mammalian cells cyclin E1,
also known as cyclin E, is synthesized in late G1 phase, where its
activation of Cdk2 stimulates proliferation by promoting G1 phase
progression, initiation of DNA replication, and centrosome duplication
(Hwang and Clurman, 2005). Cyclin E is degraded during S phase by
ubiquitin-dependent proteolysis. The ubiquitin ligase SCFCdc4 (Skp1-
Cullin1-Fbox) targets cyclin E for ubiquitination and subsequent
degradation by the 26S proteasome (Koepp et al., 2001; Strohmaier
et al., 2001). Members of the SCF family of ubiquitin ligases contain a
linker protein Skp1, a scaffold protein Cul1/Cdc53, a ring-ﬁnger protein
Rbx/Roc1, and a variable Fbox protein that determines substrate
speciﬁcity. The human Fbox protein hCdc4 (also known as Fbw7,hSEL-10, and hAgo) recognizes phosphorylated cyclin E (Hao et al.,
2007; Koepp et al., 2001; Sangfelt et al., 2008; van Drogen et al., 2006).
The three alternatively spliced isoforms of hCdc4 localize differently
within the cell; Cdc4 α and γ isoforms are nuclear, whereas the β
isoform is cytoplasmic (Ye et al., 2004).
Phosphorylation of human cyclin E on threonine 380 (T380) by
GSK3β and on serine 384 (S384) by Cdk2 is required for cyclin E
recognition by SCFCdc4 and its subsequent degradation (Ye et al.,
2004). Phosphorylation of T62 may serve as a priming event for T380
phosphorylation (Ye et al., 2004) or cyclin E turnover may be directly
dependent on T62 phosphorylation (Welcker et al., 2003), although
its phosphorylation has not been shown in vivo. Defects in cyclin E
turnover lead to increased protein and its presence throughout the
cell cycle (Ekholm-Reed et al., 2004). Cdc4 loss of function has been
described in breast and ovarian cancer cell lines (Moberg et al., 2001;
Strohmaier et al., 2001) and in primary endometrial, pancreatic, and
colon cancers (Calhoun et al., 2003; Rajagopalan et al., 2004; Spruck
et al., 2002); consistent with impaired cyclin E degradation contrib-
uting to malignant transformation (Ekholm-Reed et al., 2004).
In Xenopus laevis embryos, three isoforms of cyclin E have been
cloned: E1 (Chevalier et al., 1996; Rempel et al., 1995), E2 (Gotoh et al.,
2007) andE3 (Chevalier et al., 1996). Cyclins E1 andE3 are thought tobe
Table 1
PCR primer pairs for cloning and site-directed mutagenesis of Cyclin E.
Mutant Primer pair
Cloning ORFs out
of pet21A
Forward: CACGAATTCTGCACCAGTGATAAGCAATCCTGC
Reverse: CCGTCTAGAGTCTGCTCGATCAGTTTT
S398A Forward:
GGTGTTCTGACTCCTCCCCAGGCGAACAAGAAACAGAAATCTGATC
Reverse:
GATCAGATTTCTGTTTCTTGTTCGCCTGGGGAGGAGTCAGAACACC
S398D Forward:
GGTGTTCTGACTCCTCCCCAGGATAACAAGAAACAGAAATCTGATC
Reverse:
GATCAGATTTCTGTTTCTTGTATCCCTGGGGAGGAGTCAGAACACC
T394A Forward: GGC GAG GCG CCA GAA CAC
Reverse: GTGTTCTGGCGCCTCCCC
T394D Forward: GTTCTGGATCCTCCCCAGAG
Reverse: CTCTGGGGAGGATCCAGAACACC
S398A/T394A Forward: GTTCTGGCGCCTCCCCAGGCTAACAAGAAACAGAAATCT
Reverse: AGATTTCTGTTTCTTGTTAGCCTGGGGAGGCGCCAGAAC
S398D/T394D Forward:
GTGTTCTGGATCCTCCCCAGGATAACAAGAAACAGAAATCTG
Reverse:
CAGATTTCTGTTTCTTGTTATCCTGGGGAGGATCCAGAACAC
T75A Forward: GTTCCTCTTTTTCTGGAGCAGGAATCAATTTGTGGGG
Reverse: CCCCACAAATTGATTCCTGCTCCAGAAAAAGAGGAAC
NLS* Forward:
TGTAGTGTGCGCTCCAGAGCTGCTGCTGCAGATGTGGCTATTTTC
Reverse:
GAAAATAGCCACATCTGCAGCAGCTCTGGAGCGCACACTACA
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(Chevalier et al., 1996). Cyclin E1 was the ﬁrst cloned and is the best
characterized in Xenopus. Similar to cancer cells with Cdc4 defects,
cyclin E1 is abundant in eggs and its level is high and constant following
fertilization through the ﬁrst 12 rapid cell divisions (Hartley et al., 1996;
Rempel et al., 1995). In contrast, cyclins A1, B1 and B2 ﬂuctuate with
each cell cycle in Xenopus embryos, similar to normal adult somatic
cells, peaking during mitosis and then subsiding despite ongoing
translation (Hartley et al., 1996). The ﬁrst cell cycle following
fertilization is 75 min in length while cell cycles 2–12 are 25 min,
alternating rapidly between mitosis and DNA synthesis with no
detectable G phases (Newport and Kirschner, 1982a, 1982b). These
divisions are mitogen-independent and lack transcription. After the
12th division, (~6 hours post fertilization, hpf) during the period of
development called the midblastula transition (MBT), the rapid
embryonic cell cycle begins remodeling to the adult cell cycle, contain-
ing G phases and checkpoint controls. At theMBT, zygotic transcription
begins and cyclin E1 protein is abruptly destabilized by an undeﬁned
mechanism (Hartley et al., 1997; Howe and Newport, 1996; Rempel et
al., 1995). Following the MBT, cyclin E1 is expressed in a G1/S speciﬁc
manner, cyclin D and the Cdk inhibitor p27 are produced (Shou and
Dunphy, 1996; Su et al., 1995), and cells gain the ability to undergo cell
cycle arrest and apoptosis in response to DNA damage (Anderson et al.,
1997; Sible et al., 1997). This process can be viewed simplistically as the
reverse of a normal human cell's progression towards cancer.
Degradation of cyclin E1 at theMBT does not require new transcription,
an increased nuclear to cytoplasmic ratio, or cell cycle expansion
(Hartley et al., 1997; Howe and Newport, 1996).
In contrast to maternally expressed cyclin E1, zygotic cyclin E2 is
barely detectable until early gastrula stages, when it increases and
remains constant until tadpole stages (Gotoh et al., 2007). Complete
knock down of cyclin E2 results in embryonic death at the end of
gastrulation, whereas its partial knock down allows survival (Gotoh et
al., 2007). These results point to distinct roles of these two cyclins in
embryogenesis.
Similar to Xenopus, maternal cyclin E1 protein level is constant in
the early Drosophila, sea urchin, mouse and C. elegans embryo and
downregulated during development (Brodigan et al., 2003; Damjanov
et al., 1994; Knoblich et al., 1994; Sumerel et al., 2001). Given its
markedly distinctive pattern of expression during the embryonic and
adult cell cycle with the time of its disappearance corresponding to
cell cycle remodeling, maternal cyclin E1 degradation has been
proposed to be necessary for establishment of the adult cell cycle
(Hartley et al., 1997; Howe and Newport, 1996; Rempel et al., 1995;
Richardson et al., 1993). We set out to deﬁne the mechanism of
Xenopus cyclin E1 degradation at the MBT in order to be able to
determine its developmental signiﬁcance, as well as to potentially
identify novel ways of reducing cyclin E1 protein levels in cancer in
future studies. For the remainder of this study, we will refer to
Xenopus cyclin E1 as cyclin E.
Materials and methods
Embryos
X. laevis embryos were obtained by inducing egg laying with
hormones followed by in vitro fertilization using standard methods
(Hartley et al., 1996). Embryos were microinjected with capped, in
vitro transcribed mRNA into the animal pole of one cell at the two-cell
stage. Embryos were staged according to Nieuwkoop and Faber
(1994) and collected at the stated time post-fertilization.
Proteasome and nuclear import inhibition
Proteasome inhibitors Clasto-Lactocystin β-Lactone (CLBL; Calbio-
chem, La Jolla, CA) and MG132 (Cayman Chemical Company, AnnArbor, MI), or wheat germ agglutinin Alexa 633 Fluor conjugate
(WGA; Invitrogen, Eugene, OR), were mixed with mRNA at the ﬁnal
concentration indicated and injected into 1 cell of 2-cell embryos.Constructs
Cloning and site-directed mutagenesis primers are listed in
Table 1. Cyclin E mutants T394A, T394D, S398A, S398D, and T75A
were generated by site directed mutagenesis of the cyclin E1 gene
(Genbank accession no. Z13966) in the pET21A vector. T394A S398A
and T394D S398D mutants were generated by site directed muta-
genesis in the context of T394A and T394D mutants, respectively, in
pET21A using the Stratagene (Santa Clara, CA) Quick Change Site-
Directed Mutagenesis protocol. The open reading frames of wild type
cyclin E and its mutantswere cloned by PCR out of pET21awithout the
stop codon. An EcoRI restriction site plus four additional nucleotides
were added to the forward primer to ensure in-frame cloning and
prevent generation of potential novel phosphorylation sites. An XbaI
restriction site was added to the reverse primer. The PCR product was
digested with XbaI and EcoRI and ligated into pCS2mt-GFP (Addgene,
Cambridge, MA) cut with the same enzymes using a Quick ligation kit
(New England Biolabs, Ipswich, MA). The cyclin E nuclear localization
signal (NLS) residues 24–29, RSRKRK, was mutated to RSRAAA by site
directed mutagenesis of cyclin E1 in pCS2mt-GFP. Primers were
identical to those used by Moore et al.(2002) except that the primers
were changed to reﬂect a difference found in sequence. 10 ng of DNA
was used for transformation of DH5α. Clones were selected and
veriﬁed by restriction digest and sequencing.In vitro transcription
Plasmids were linearized with Not I and transcribed with SP6 RNA
polymerase according to the manufacturer's instructions (Promega,
Madison, WI). 1–2 μg of the in vitro transcribed RNAs were analyzed
on formaldehyde gels to check quality. Capped transcripts were
injected into 1 cell of a 2-cell embryo (0.5 ng), between 1.5–2 h post-
fertilization.
67Y. Brandt et al. / Developmental Biology 355 (2011) 65–76Western analysis
3–5 embryos were collected on dry ice at the indicated hour post-
fertilization (hpf). To prepare cytoplasmic extracts, embryos were
homogenized in extraction buffer (EB, 10 μl/per embryo) containing
protease inhibitors (Hartley et al., 1997) and centrifuged at 12,000 rpm
for 10 min. Supernatant (cytoplasmic extract) was removed to a new
tube, avoiding the yolk protein, and diluted with 6× loading buffer and
heated at 95 °C for 5 min. For detection of ubiquitinated cyclin E,MG132
was added to the EB to the ﬁnal concentration of 20 μM. One embryo
equivalent (or 4.5 embryo equivalents for detectingubiquitinated cyclin
E) was loaded per lane and separated on 10% SDS-polyacrylamide gels.
Proteins were then transferred to a PVDF membrane using a semi-dry
blotting apparatus.Membraneswere blockedwith 5%nonfat drymilk in
Tris buffered saline, 0.05% Tween 20 (TBST) and then incubated with
Myc antibody (1:10,000 in block; Cell Signaling Technology, Danvers,
MA) for 1.5 h at room temperature (RT)or overnight at 4 °C, followedby
goat-anti-mouse horseradish peroxidase (HRP)-conjugated secondary
(1:24,000 in TBST; Santa Cruz Biotechnology, Santa Cruz, CA). Signals
were visualized using Immobilon Western Chemiluminescent HRP
substrate (Millipore Corporation, Billerica,MA). Blotswere stripped and
re-probed with β-actin antibody (1:1000 in TBST, 5% BSA; Santa Cruz
Biotechnology) followed by donkey-anti-goat HRP (1: 5000 in TBST).
Blots were imaged and quantiﬁed using a Kodak MI Image Station and
associated software.
Immunoﬂuorescence analysis
3–5 embryos were collected at the indicated time points and ﬁxed
in 3.7% formaldehyde/phosphate buffered saline (PBS) for 2 h on a
nutator. Embryos were then transferred into Dent's ﬁxative (4 parts of
MeOH and 1 part DMSO), and incubated at −20 °C for at least 48 h.
Embryos were rehydrated in a graded series of methanol and washed
twice for 10 min in PBS. Rehydrated embryos were hemi-sectioned
and all incubations and washes were performed at 4 °C on a nutator.
Blocked embryos were incubated in either anti-Myc (1:2000; Cell
Signaling Technology) or anti-cyclin E (1:50; Dr. Michel Philippe,
University of Rennes, Rennes, France) in PBT overnight. The embryos
were washed four times with PBT, and incubated in Alexa Fluor 488
conjugated goat-anti-mouse or goat-anti-rabbit (Molecular Probes,
Eugene, OR) in PBT (1:200) overnight. Embryos were washed 3 times
with PBT, nuclei counterstained with 4′,6′-diamidino-2-phenylindole
(DAPI) in PBS (1:3000 dilution of 1 mg/ml) for 30–60 min, washed
extensivelywithPBS, andmounted indepression slidesusingVectashield
mountingmedia (Vector Laboratories, Burlingame, CA) and coverslipped.
An empirically chosen constant exposure timewas used for imaging on a
Zeiss LSM 510 confocal microscope equipped with a META detector, a
Zeiss Axiovert 200 microscope equipped with a Hamamatsu camera, a
Zeiss Axioplan 2 with a CoolSnap HQ camera, or an Olympus DSU
Spinning Disc Confocal System.
Immunoprecipitation
Cytoplasmic extract was prepared from embryos injected with WT
cyclin E mRNA as described above in Western analysis, except that EB
contained 1.5× the concentration of protease inhibitors and was
supplementedwithMG132 to 20 μMﬁnal concentration. All procedures
were carried out at 4 °C, unless noted otherwise. Seven and a half
embryo equivalents of cytoplasmic extract were diluted in a total
volume of 100 μl of EB and precleared with 25 μl of 50% protein A
agarose in EB for 25 min on a rocker. After brief centrifugation, the
supernatant was transferred into a fresh tube and 2 μl of anti-Myc or
normalmouse IgGwas added and incubated for 4 h. 25 μl of 50% protein
A agarose was added and incubated with rocking for 2 h. Samples were
brieﬂy centrifuged and supernatant removed. The protein A agarose
beadswere thenwashed twicewith both low andhigh salt TENT buffers(20 mM Tris–HCl, pH 7.4; 5 mM EDTA; 1% Triton X-100; containing
either 100 mMor 1 MNaCl, respectively), resuspended in 50 μl of 1×gel
loading buffer and heated at 95 °C for 5 min. Samples were loaded onto
10% polyacrylamide gels followed byWestern blottingwith either anti-
Myc (1:5000) followed by goat-anti-mouse HRP (1:10,000), or Lys48
speciﬁc anti-Ubiquitin antibody (Cell Signaling Technologies) followed
by goat-anti-rabbit HRP (1:3000). To determine the relative efﬁciency
of the immunoprecipitation (IP), the starting extract (input) and the
supernatant remaining after IP (supernatant) were also analyzed by
western analysis for anti-Myc.
Two-dimensional gel electrophoresis-western analysis
IPs were carried out as described in the previous section, except that
after immunoprecipitation the protein A agarose beads were treated
with Protein Phosphatase I (PP1; NewEngland Biolabs, Ipswich,MA), or
PP1 buffer alone for 30 min at room temperature. PP1 and buffer treated
beads were washed twice with low and high salt TENT buffers, three
times with dH2O and resuspended in rehydration buffer (2% CHAPS,
20 mM DTT, 9.5 M urea, containing traces of bromophenol blue).
Samples were absorbed overnight onto IPG strips (pH 3–10, nonlinear)
(Biorad, Hercules, CA) at RT and subjected to isoelectric focusing. Strips
were then layered on top of 10% gels (Criterion precast Tris–HCl gel,
Biorad) and proteins were separated by electrophoresis and transferred
to PVDF membrane. Western blot analysis was performed using anti-
Myc antibody (1:5000) andgoat-anti-mouseHRP conjugated secondary
(1:4000 dilution). Signals were visualized using Immobilon Western
Chemiluminescent HRP substrate (Millipore Corporation).
Results
Differential phosphorylation regulates cyclin E stability in Xenopus laevis
embryos
The phosphorylation sites that are important for human cyclin E
recognition by SCFCdc4, T380, S384, and T62 (Welcker et al., 2003; Ye et
al., 2004) are conserved in Xenopus and correspond to T394, S398 and
T75.Weobservedpreviously that anunphosphorylatableT394 to alanine
(T394A)mutation stabilizes cyclin E and its associated Cdk2 activity past
theMBT, when cyclin E is usually degraded and Cdk2 activity drops (R.S.
Hartley, unpublished). In addition, twoXenopus orthologs of hCdc4 have
been cloned: α and β (Almeida et al., 2010). Both isoforms are present
throughout development, can promote destruction of cyclin E and
therefore represent potential candidates for its degradation at the MBT.
Based on the above ﬁndings, we hypothesized that phosphorylation of
cyclin E at T394, S398, and T75destabilizes cyclin E at theMBT inXenopus
laevis embryos.
To examine contribution of individual phosphorylation events to
cyclin E turnover,wemutated T394 and S398 to either alanine (prevents
phosphorylation) or aspartic acid (mimics constitutive phosphoryla-
tion) and T75 to alanine by site-directed mutagenesis. We also created
doublemutants affecting twoof thepotentiallymost important residues,
T394 and S398. If phosphorylation at these residues is important for
turnover, mutating them should affect cyclin E stability.Wild type (WT)
cyclin E and its mutants were cloned into the pCS2mt-GFP vector that
contains both Myc6 and GFP tags, in vitro transcribed, and mRNAs
injected into 2-cell embryos for in vivo translation.
Western blots of embryo time courses using an antibody against
the Myc-tag are shown in Fig. 1. Cyclin E level was normalized to β-
actin as a loading control, as its level remains constant throughout
development. WT cyclin E and its mutants accumulated to compa-
rable levels (Figs. 1A–I). Fig. 1A shows that WT cyclin E accumulated
until 6 h post fertilization (hpf), corresponding to the MBT, when it
reached its maximum (taken as 100%) and started to decrease by
8 hpf. Its abundance was reduced to 69% of maximum by 8 hpf and
was almost undetectable by 25.5 hpf when 1.3% remained (Fig. 1J).
Fig. 1. Differential phosphorylation regulates cyclin E stability in Xenopus laevis embryos. Western blot analysis of cytoplasmic extracts from embryos injected with mRNA encoding
A) exogenous wild type (WT) cyclin E, B) Myc6-GFP, C–I) cyclin E phosphorylation mutants, as indicated. 2-cell embryos (1.5–2 h post fertilization, hpf) were microinjected with
0.5 ng of in vitro transcribedmRNA and collected at time points indicated on the top of each blot (hpf). One embryo equivalent was analyzed by immunoblotting with aMyc antibody
(αMyc). Blots were stripped and re-probed for actin (αAct) as a loading control. In panel I, Un indicates uninjected embryos used as a negative control. Markers are to the right in
kDa. Representative blots are shown from ﬁve experiments for A, D, F, and I; four experiments for C, and 3 experiments for B, E, G, and H. J–M) Graphs showing cyclin E levels as
percent of normalized expression based on mean values from all experiments. For each plot the maximal normalized value was taken as 100% and relative intensities of all bands
were represented as percent of normalized expression. Each graph has WT cyclin E plotted for easy comparison.
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(Hartley et al., 1997; Rempel et al., 1995), validating our approach of
using exogenous protein to study cyclin E turnover. In contrast,
control Myc6-GFP protein, translated from empty vector mRNA,
increased in a linear fashion until 25.5 hpf (Figs. 1B and J). We
detected no signal in uninjected embryos collected at any of the time
points (Fig. 1I, the lane labeled Un, is an uninjected embryo at 6 hpf).
In comparison to WT cyclin E, the T394A mutant accumulated
more slowly, but maintained a higher level after the MBT through at
least 25.5 hpf, when 70% of the maximum protein remained (Figs. 1C
and K). The T394D phosphomimetic mutant partially restored cyclin E
turnover, as seen in Figs. 1D and K (47% of maximum remained at
25.5 hpf). We next assessed the importance of S398 in cyclin E
turnover. The S398A mutant was even more resistant to degradation
than the T394A mutant, resulting in the presence of 80% of the
maximal level of protein through 25.5 hpf. (Figs. 1E and L). The S398D
phosphomimetic mutation restored cyclin E turnovermore effectively
than the T394D mutation, with only 19% of maximal cyclin E protein
present by 25.5 hpf (Figs. 1F and L). The T75A mutant delayed but didnot prevent cyclin E turnover (Figs. 1I and J), consistent with the
observation that the corresponding residue T75 in human cyclin E
does not play a major role in its turnover (Ye et al., 2004). Mutating
both T394 and S398 residues to alanine caused accumulation of cyclin
E until 25.5 hpf, when the majority of wild type cyclin E is already
degraded (Figs. 1G and M). Finally, T394D S398D double mutants
exhibited decreased protein turnover (Figs. 1H andM) as compared to
T394A S398A, with only 38% of maximum protein remaining at
25.5 hpf. These data indicate that similarly to human cyclin E,
corresponding residues in Xenopus cyclin E serve as phosphodegrons,
with their phosphorylation mediating cyclin E destabilization,
suggesting conservation of destruction pathways. Of the single
mutants, S398A was the most stable followed by T394A and T75A.
The fact that the T394AS398A mutant exhibited complete stabiliza-
tion, points toward the requirement of at least two phosphorylation
events marking Xenopus cyclin E for destruction.
In order to determine if a change in phosphorylation accompanies
the degradation of cyclin E1 at the MBT in vivo, we analyzed the
phosphorylation state of WT cyclin E translated in pre-MBT (4 hpf)
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followed by Western blotting. WT cyclin E was immunoprecipitated
from cytoplasmic extracts prepared from pre-MBT or MBT embryos.
Phosphatase treatment of WT cyclin E from pre-MBT embryos did not
result in signiﬁcant mobility differences (Fig. 2A, top and bottom). On
the contrary, at theMBT (6 hpf), there is a pronounced shift of cyclin E
toward a more acidic pH, compared to the phosphatase treated
sample (Fig. 2B top and bottom). These results suggest that in pre-
MBT(4 hpf) embryosphosphorylationof cytoplasmic cyclin E isminimal,
whereas at theMBT(6 hpf) its phosphorylation is dramatically increased,
corresponding to the beginning of its degradation.
Nuclear accumulation at the MBT precedes cyclin E degradation
Mammalian cyclin E–Cdk2 complexes reside in the nucleus, (Delk et
al., 2009; Jackman et al., 2002), whereas cyclin E by itself shuttles
between the nucleus and cytoplasm inmammalian cells (Jackman et al.,
2002). Inmammalian cells, Cdc4α andγ are found in the nucleus (Ye et
al., 2004) where they can function sequentially to promote cyclin E
ubiquitination (van Drogen et al., 2006). First, Cdc4 α binds both Pin1,
theprolyl cis/trans isomerase, and cyclinE–Cdk2complex andpromotes
Pin1 isomerization of cyclin E. This modiﬁcation renders cyclin E
susceptible to ubiquitination by Cdc4γ.When cyclin E is overexpressed,
Cdc4 α alone is sufﬁcient for its turnover (Grim et al., 2008; Sangfelt et
al., 2008). Cdc4 β resides in the cytoplasm and is also capable of
ubiquitinating cyclin E, leading to its degradation (van Drogen et al.,
2006; Ye et al., 2004). In sea urchin and Drosophila embryos, cyclin E is
nuclear (Richardson et al., 1993; Sumerel et al., 2001). In MBT Xenopus
embryos, cyclin E is found in the nucleus just prior to its degradation
(Chevalier et al., 1996). The localizationof Xenopus cyclin Ehas not been
studied in the early embryonic cell cycle in vivo. We hypothesized that a
change in localization contributes to Xenopus cyclin E destabilization at
the MBT. To test this hypothesis, cyclin E localization within cells in
whole mount pre-MBT (4 hpf), MBT (6 hpf) and post-MBT (8 hpf)
embryos was assessed by confocal immunoﬂourescence analysis (IFA)
using a Xenopus cyclin E antibody (Chevalier et al., 1996) to detect
endogenous cyclin E (courtesy of Dr. Michel Philippe, University of
Rennes, France).
Fig. 3A shows that in pre-MBT embryos, cyclin E was primarily
cytoplasmic. At MBT, when the abundance of cyclin E starts to
decrease, it began to appear in the nucleus, with some cytoplasmic
staining still present (Fig. 3B), consistent with a previous reportFig. 2. Phosphorylation of cytoplasmic cyclin E is dramatically increased at the MBT. Tw
immunoprecipitated from pre-MBT (4 hpf) and MBT (6 hpf) embryos. Embryos were injecte
with Myc antibody. Half of the immunoprecipitate was treated with protein phosphatase 1
polyacrylamide gels, and transferred to PVDF membrane followed by immunoblotting with M
(3 to 10) is displayed at bottom. Arrows indicate position of full length Myc-cyclin E on blo(Chevalier et al., 1996). Note that individual cells of the embryo
become progressively smaller as embryos continue to divide without
growth. Post-MBT, cyclin E remained both nuclear and cytoplasmic
(Fig. 3C), conﬁrmed by colocalization of cyclin E with nuclear DAPI
staining (data not shown). Interestingly, neither DAPI nor TOPRO
nuclear dyes appear to stain pre-MBT nuclei efﬁciently. However,
since cyclin E was cytoplasmic pre-MBT and did not localize to any
intracellular compartments or structures, this did not interfere with
the interpretation of results. Localization of WT Myc-tagged cyclin E
was similar to that of endogenous cyclin E; cytoplasmic pre-MBT, and
both nuclear and cytoplasmic from theMBT on (Fig. 4B). Importantly,
Myc6-GFP protein expressed from an empty vector remained cytoplas-
mic in pre-MBT, MBT and post MBT embryos (Fig. 4D). Nonspeciﬁc
ﬂuorescence was not observed in control embryos microinjected with
H2O (vehicle, for Myc-cyclin E mRNA) or incubated with secondary
Alexa-488 conjugated antibody alone (for both endogenous and
exogenous cyclin E detection, data not shown). Based on these results,
we concluded that in agreement with our hypothesis, cyclin E re-
localizes from the cytoplasm to the nucleus at the MBT.
Phosphorylation of T394, S398 or T75 is not required for nuclear
localization
Phosphorylation can serve as a signal for nuclear localization of
cyclins (Li et al., 1997). To determine if mutating the phosphorylation
sites involved in cyclin E degradation impairs its nuclear accumulation
at the MBT, we used IFA to examine localization of the cyclin E
phosphomutants. Figs. 4B and C show that T394A S398A and T394D
S398D mutants were localized similarly to WT cyclin E1 in pre-MBT,
MBT and post-MBT embryos. Localization of T394A, T394D, S398A,
S398D, and T75A mutants was also similar to WT cyclin E1 (data not
shown). The absence of obvious mislocalization of cyclin E1 mutants
does not exclude the possibility that the dynamics of accumulation of
these mutants inside the nucleus might be affected, or that phosphor-
ylation (or other post-translational modiﬁcations) at undeﬁned sites
may be required for nuclear localization.
Cyclin E degradation is dependent on its localization to the nucleus
In cycling extracts, Xenopus cyclin E–Cdk2 is taken into the nucleus
via direct interaction of cyclin Ewith the nuclear pore receptor importin
α/β (Moore et al., 1999). A basic nuclear localization signal (NLS) iso-dimensional gel electrophoresis followed by Western blot analysis of WT cyclin E
d with WT cyclin E mRNA and cytoplasmic extracts subjected to immunoprecipitation
, (+PP1). Samples were subjected to isoelectric focusing, electrophoresed on 10% SDS-
yc antibody. Markers are indicated on the left and right in kDa. Direction of pH gradient
ts. IP, immunoprecipitation, WB, Western blot. Experiment was repeated 2 times.
Fig. 3. Endogenous cyclin E accumulates in the nucleus at the MBT. Immunoﬂuorescence analysis of endogenous cyclin E in A) pre-MBT (4 hpf), B) MBT (6 hpf), and C) post-MBT
(8 hpf) embryos. Embryos were ﬁxed and stained with an antibody against Xenopus cyclin E (αcycE) followed by an Alexa488 conjugated secondary antibody. Merge panel in A is a
merged image of Alexa488 and the light channel, in B, Alexa488 and DAPI, and in C, Alexa488, DAPI and light. Magniﬁcation is 10× for A and B; 20× for C. Scale bars are 100 μM.White
arrows show nuclei stained for cyclin E. Experiment was performed 3 times.
70 Y. Brandt et al. / Developmental Biology 355 (2011) 65–76responsible for nuclear translocation of Xenopus cyclin E; RSRKRK
spanning residues 24–29 in the N terminus (Moore et al., 2002). To
determine if cyclin E turnover is dependent on nuclear import we co-
injected wheat germ agglutinin (WGA) into the embryos together with
the WT cyclin E mRNA. We choseWGA because it blocks nuclear pores
(Yoneda et al., 1987) and is routinely used to inhibit nuclear import.
First, we empirically determined the concentration of WGA that
completely abolished nuclear accumulation of Myc6-cyclin E-GFP at
the MBT. Fig. 5A shows confocal images of live MBT embryos injected
with theWT cyclin EmRNAusing aGFPﬁlter.WT cyclin E is cytoplasmic
in WGA-treated embryos compared to the control without the WGA
(Fig. 5A, white arrows show nuclei staining for cyclin E, while black
arrows indicate cells with cytoplasmic cyclin E). Fig. 5B shows ﬁxed
WGA-treated MBT embryos stained with the Myc antibody and
counterstained with DAPI to show nuclei. Blocking nuclear import
resulted in an increase of cytoplasmic cyclin E as seen in comparison to
control embryos (Fig. 5C), throughout the entire 25.5 h timecourse, as is
veriﬁed in theWestern blots in Figs. 5E and F. Moreover, the maximum
amount of cyclin E in WGA injected embryos exceeded the maximum
amount of cyclin E in control embryos by1.6-fold (Fig. 5H).
To speciﬁcally block cyclin E nuclear import, we mutated its
nuclear localization sequence (NLS) from RSRKRK to RSRAAA (cyclin
E-NLS*), a mutation that abolishes nuclear import in Xenopus egg
extracts (Moore et al., 2002). The accumulation of cyclin E-NLS* in the
nucleus at 6 hpf is reduced, but not completely abolished (Fig. 5D).
Figs. 5G and H show that cyclin E-NLS* continues to accumulate up
until 12 hpf (100%) and then starts to degrade (42% remaining at
25.5 hpf), consistent with reduced nuclear accumulation. These
results suggest that nuclear import of cyclin E in MBT embryos does
not require the NLS. Therefore, we conclude that cyclin E degradation
after the MBT is dependent on its import into the nucleus.
Proteasome inhibition increases cytoplasmic cyclin E levels
SinceXenopus cyclin Edegradation requires similarphosphorylation
events to that of mammalian cyclin E degradation, we tested whether
cyclin E degradation is mediated by the 26S proteasome. Cyclin E
stability was monitored by Western blot analysis of embryos injected
with Clasto-Lactocystin β-Lactone (CLBL), a very speciﬁc and potent
inhibitor of the 20S proteasome (Gaczynska and Osmulski, 2005). 20S is
a core complex of the 26S proteasome responsible for degradation of
ubiquitinated target proteins (Konstantinova et al., 2008). CLBL was co-injected into one cell of a two cell embryo together with WT cyclin E
mRNA. CLBL injection caused progressive accumulation of exogenous
cyclin E past theMBTwhile in embryos injectedwithWT cyclin EmRNA
in DMSO (vehicle for CLBL), exogenous cyclin E decreased following the
MBT as expected (not shown). As CLBL also perturbed nuclear
translocation of cyclin E at the MBT, it remained unclear if cytoplasmic
accumulation of cyclin E following CLBL treatmentwas a direct result of
proteasome inhibition or a nonspeciﬁc impairment of nuclear import.
Thereforewe testedwhether a chemically distinct inhibitor, the peptide
aldehydeMG132, could impede cyclin E degradation by the proteasome
without adversely affecting its nuclear import.
Similar to CLBL, MG132 inhibited destruction of cyclin E in a dose-
dependent manner (Figs. 6A–E). Embryos microinjected with 20 μM
MG132 exhibited maximal accumulation of cyclin E at the MBT (6 hpf)
followed by a rapid decrease (Fig. 6B). Although cyclin E accumulated to
higher levels up to the MBT in embryos microinjected with 20 μM
MG132 compared to control DMSO injected embryos (compare to
Fig. 6A), it was still efﬁciently eliminated following the MBT, suggesting
that the capacity of the cellular degradation machinery was not
compromised by cyclin E overexpression alone. At an MG132
concentration of 30 μM, there was a signiﬁcant increase in cyclin E
remaining in the cytoplasm after the MBT (Fig. 6C). 40 μM of MG132
completely inhibited cyclin E destruction after the MBT causing further
accumulation in the cytoplasm throughout the duration of the time
course, until it reached its maximum at 12 hpf (Figs. 6D and E). IFA of
ﬁxed embryos showed that 40 μM of MG132 allowed proper nuclear
redistribution of WT cyclin E at theMBT (6 hpf) (Fig. 6F, white arrows),
as observed in control DMSO injected embryos (Fig. 6G, white arrows).
Neither CLBL nor MG132 treated embryos survived past 12 hpf, likely
due to the previously reported induction of apoptosis via multiple
secondary mechanisms following cyclin E overexpression past the MBT
(Mimnaugh et al., 2001; Richard-Parpaillon et al., 2004). These ﬁndings
suggest that the reduction in cyclin E level after the MBT is mediated
through proteasomal degradation.
Cyclin E is ubiquitinated in vivo starting at the MBT
Phosphorylation of human cyclin E marks it for ubiquitination
and degradation by the 26S proteasome (Clurman et al., 1996; van
Drogen et al., 2006; Won and Reed, 1996). Since both phosphory-
lation and the proteasome appear to play a role in cyclin E turnover
in Xenopus laevis embryos, and because MG132 is a nonspeciﬁc
Fig. 4. Exogenous cyclin E and its phosphorylation mutants accumulate in the nucleus at the MBT. Immunoﬂuorescence analysis of WT cyclin E in embryos. Embryos were injected
with the indicated mRNA at the 2-cell stage, ﬁxed at the time indicated at the top of the ﬁgure, and stained with anti-Myc followed by an Alexa488-conjugated secondary. A) WT:
wild type cyclin E, B) TASA: T394A S398A, C) TDSD: T394D S398D and D) Myc6-GFP. White arrows mark individual nuclei. Magniﬁcation is 10×. Scale bars are 100 μM. Experiment
was performed 3 times.
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degradation of cyclin E is preceded by its ubiquitination. Detection of
ubiquitination of endogenous proteins is problematic due to their
rapid degradation via proteasomal catabolism and trimming of
linear or branched ubiquitin chains by ubiquitin-cleaving isopepti-
dases (Weissman, 2001). To overcome this limitation, we over-
expressed WT cyclin E and overexposed Western blots to detect
higher molecular weight ubiquitinated isoforms of cyclin E in cytoplas-
mic embryo extracts. These isoforms were detected starting at MBT
(6 hpf), but not in pre-MBT embryos collected at 4 hpf (Fig. 7A). These
slower migrating forms become more prominent with progression of
time at 8 and 10 hpf and no bands were observed in uninjected control
embryos (data not shown).
To further conﬁrm the presence of ubiquitinated cyclin E, we
immunoprecipitated WT cyclin E from cytoplasmic extracts treated
withMG132 to inhibit destruction of ubiquitinated proteins. Half of theimmunoprecipitated protein was subjected to Western blotting with
anti-Myc and half with anti-ubiquitin, Lys-48-speciﬁc, a modiﬁcation
associated with proteasomal degradation. In this experiment slower
migrating forms of cyclin E were detected by immunoblotting with
anti-Myc starting at the MBT in 6 and 8 hpf samples, but not at 4 hpf
(pre-MBT) (Fig. 7C,αMyc). No signalwas detected in precipitates using
control IgG (Fig. 7C, IgG) or in anti-Myc immunoprecipitates from
embryos in which WT cyclin E mRNA was not injected (Fig. 7C, αMyc,
Un). Cyclin E was efﬁciently immunoprecipitated from the extracts
since only trace amounts of it remained in the supernatants after the
anti-Myc IP as compared to the IgG IP and the total before IP (Fig. 7D,
compare with total, Fig. 7B). We also observed a series of higher
molecular weight isoforms in the ubiquitin blots fromMBT (6 hpf) and
post-MBT (8 hpf) embryos, but not in pre-MBT (4 hpf) and uninjected
embryos (Fig. 7E), conﬁrming that cyclin E is ubiquitinated beginning at
the MBT.
72 Y. Brandt et al. / Developmental Biology 355 (2011) 65–76Discussion
The objective of this studywas to deﬁne themechanism ofmaternal
cyclin E degradation in Xenopus laevis embryos. Xenopus cyclin E is 90%Fig. 5. Blocking nuclear import prevents exogenous cyclin E degradation. 2-cell embryos w
wheat germ agglutinin (WGA, 235 nM ﬁnal concentration) and collected at the indicated ti
cyclin E-GFP at the MBT (6 hpf) without WGA (−WGA) and with WGA (+WGA) viewed t
embryo expressingWT cyclin E localized in the cytoplasm. B and C) MBT (6 hpf) embryos inj
stained with αMyc followed by an Alexa488-conjugated secondary. Nuclei were counterstain
(B) or nucleus (C); insets are a zoom of these cells. Magniﬁcation is 10×. D) MBT embryos
Alexa488-conjugated secondary. Nuclei were counterstained with DAPI (DAPI). White arrow
D. E–G)αMycWestern blots of cytoplasmic lysates from embryos injected withWT cyclin Em
re-probed for actin (αAct) as a loading control. Markers are on the right in kDa. H) Graph sho
band intensity normalized to actin in WGA treated embryos compared to not treated contridentical to human cyclin E at the nucleotide level, and the phosphor-
ylation sites responsible for human cyclin E turnover are conserved in
the Xenopus protein. Therefore, we tested the hypothesis that the
mechanism of cyclin E degradation is conserved between the twoere microinjected with 0.5 ng of in vitro transcribed WT cyclin E mRNA together with
me points (hpf). A) Live confocal images of embryos showing localization of WT Myc6-
hrough a GFP ﬁlter. White arrows indicate nuclei, black arrows outline cells within the
ected withWT cyclin E mRNA in the presence (B) or absence (C) ofWGAwere ﬁxed and
ed with DAPI (DAPI). White arrows show cells expressingWT cyclin E in the cytoplasm
injected with cyclin E-NLS* mRNA were ﬁxed and stained with αMyc followed by an
s show nuclear cyclin E inset is a zoom of these cells. Scale bars are 100 μM for panels A–
RNA andWGA (E),WT cyclin EmRNA (F), or cyclin E-NLS* (G). Blots were stripped and
wing mean values (from 5 experiments for E and F, and 3 experiments for G) of cyclin E
ols.
Fig. 6. Proteasome inhibition prevents cyclin E degradation. A, B, D–F: Myc Western blots as described in Fig. 1 except that embryos were microinjected with WT cyclin E mRNA and
A) DMSO, B) 20 μMMG132 in DMSO, C) 30 μMMG132 in DMSO, and D) 40 μMMG132 in DMSO. Representative blots from 3 experiments are shown. E) Graph of experiments shown
in A and D, respectively. Cyclin E levels were normalized to actin and expressed as percent of normalized expression. Values shown aremean±SEM. Immunoﬂuorescence analysis of
WT cyclin E in 6 hpf (MBT) embryos also injected with F) 40 μM of MG132 or G) DMSO. Embryos were ﬁxed and stained with αMyc followed by an Alexa488-conjugated secondary.
Nuclei were counterstained with DAPI. Nuclei containing WT cyclin E are marked with white arrows. Scale bars are 100 μM.
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E at the MBT is dependent on phosphorylation, is preceded by its
ubiquitination, and occurs via the proteasomal pathway. These results
suggest that the mechanism of cyclin E downregulation is conserved
between species. Unlike spatial regulation of cyclin E in humans, for
which interplay between localization and degradation is far from being
completely understood (Delk et al., 2009; Grim et al., 2008; Welcker et
al., 2004; Ye et al., 2004), in Xenopus embryos cyclin E is relocalized
from the cytoplasm to the nucleus preceding its degradation and this
relocalization is required for its turnover.
Point mutations of conserved phosphorylation sites S398, T394 and
T75 to unphosphorylatable alanine each decrease Xenopus cyclin E
turnover to various extents, reﬂecting the individual importance of each
residue in this process. S398Aand T394Amutations each render cyclin E
more resistant todegradation than T75A,while thedouble T394AS398A
mutation completely stabilizes cyclin E, resulting in its accumulation in
the cytoplasm past theMBT.Mutation of the above-mentioned residues
to phosphomimetic aspartic acid restores cyclin E turnover. There are
several examples of multiple phosphorylation events being required forefﬁcient protein degradation, including human cyclin E. Structural
analysis of human cyclin E bound to Skp1–hCdc4 complex identiﬁed
simultaneously phosphorylated T380 and S384motif as an optimal high
afﬁnity degron (Hao et al., 2007). Individual phosphorylation of these
residues mediates only weak binding to Cdc4, which can be compen-
sated for by Cdc4 dimerization, resulting in increased ubiquitination of
cyclin E. Complete stabilization of the Xenopus cyclin E T394A S398A
mutant (corresponding to T380 and S384 of human cyclin E) compared
to partial stabilization of the single mutants provides evidence that the
requirement for multiple phosphorylation events for efﬁcient turnover
is conserved between species.
In addition to the requirement for phosphorylation for cyclin E
turnover, cyclin E is cytoplasmic prior to the MBT and begins to
accumulate in the nucleus inMBT embryos. The timing of this change in
localization is consistentwith a possible role in facilitating turnover, and
agrees with the previously reported nuclear localization of cyclin E in
MBT Xenopus embryos (Chevalier et al., 1996). Phosphorylation often
serves as a signal for nuclear localization of proteins and is important for
cyclin E degradation, yet the phosphomutants examinedwere correctly
Fig. 7. Cyclin E is ubiquitinated at the MBT. Western blots of 2-cell embryos microinjected with WT cyclin E mRNA and collected at the indicated times (hpf). Cytoplasmic lysates
were prepared in the presence of 20 μMMG132. A) Lysates from four and a half embryo equivalents were immunoblotted with Myc antibody. B) Aliquots of cytoplasmic lysates from
embryos that were used for immunoprecipitation (IP) in C were immunoblotted with anti-Myc to show total amount of cyclin E in the lysates before the IP. C–E) Myc
immunoprecipitation of 7.5 embryo equivalents. Precipitation was performed withαMyc or normal mouse IgG as a control. Half of the precipitate was analyzed byWestern blotting
for Myc (C) and half for ubiquitin (E) D) Supernatants (non-precipitated protein) were also blotted for Myc to determine the amount of cyclin E remaining in the lysates after IP. Un
indicates uninjected 6 hpf embryos. Arrows indicate mobility of nonubiquitinated full lengthWT cyclin E. Markers are on the left in kDa. IP, immunoprecipitation, WB, Western blot.
Experiment was repeated 3 times.
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phospho-sites are not required for cyclin E nuclear accumulation. We
cannot exclude the possibility that changes in the rate of nuclear import
versus nuclear export of cyclin E is altered in these mutants, skewing
their nuclear to cytoplasmic distribution, which our experiments may
not have the sensitivity to detect. Interestingly, an increased nuclear to
cytoplasmic ratiowaspreviously observed for the S384Ahuman cyclin E
mutant (corresponding to themost stable of our single phosphorylation
mutants in Xenopus, S398A), which logically resulted in its decreased
turnover by Cdc4 β, the cytoplasmic isoform of Cdc4 (Ye et al., 2004).
The reason for its preferential accumulation in the nucleus was not
investigated. Given the signiﬁcant increase in cytoplasmic cyclin E
phosphorylation at the MBT, when it begins to accumulate in the
nucleus, another possibility is that phosphorylation of different residue
(s) from the ones tested in our study facilitate nuclear import. Once in
the nucleus, other phosphorylation events could facilitate its export into
the cytoplasm for ubiquitination and degradation.
Xenopus cyclin E contains a basic NLS (RSRKRK) spanning residues
24–29 in its N-terminus. This sequence is thought to be essential for
nuclear accumulation of cyclin E–Cdk2 complexes during S-phase in egg
extracts, promoting DNA replication (Moore et al., 2002). Surprisingly,
even amutation of the NLS previously shown to abolish nuclear entry in
Xenopus egg extracts (Moore et al., 2002) reduced but did not prevent
cyclin E nuclear localization at the MBT. Consistent with our results,
nuclear localization of human cyclin E cannotbe attributedentirely to its
NLS (Delk et al., 2009; Geisen andMoroy, 2002; Kelly et al., 1998; Porter
et al., 2001). A recent study showed that while some cyclin E truncation
mutants missing the NLS, also known as low molecular weight (LMW)
cyclin E isoforms (Delk et al., 2009), are cytoplasmic, others are nuclear.
We speculate that nuclear accumulation of cyclin E even in a simple
model such as Xenopus embryos might not be as straightforward aswhat current knowledge suggests, with both phosphorylation and NLS
dependent mechanisms involved. The role of individual phosphoryla-
tion sites and the corresponding kinases involved in this process remain
to be elucidated.
Degradation of Xenopus cyclin E was dependent on its nuclear
accumulation at the MBT. It was previously reported that Xenopus
cyclin E degradation is impaired by activating the MAPK pathway in
early embryos (Howe and Newport, 1996). More recent work has
shown that activation of the MAPK pathway decreases classical
nuclear import of NLS containing proteins (Faustino et al., 2008).
Taken together with our results, it is possible that MAPK activation
may impair cyclin E degradation by impeding its nuclear import. In
support of this, the bulk of MAPK is inactivated after fertilization in
Xenopus but is activated around the MBT, participating in mesoderm
induction (Gotoh et al., 1995; Hartley et al., 1994). Both Cdk2 and
GSK3β phosphorylate human cyclin E, on S384 and T380, respectively,
triggering its ubiquitination and degradation (Welcker et al., 2003). In
Xenopus cyclin E, T75 ﬁts the consensus site for Cdk2, T/SPXK/R
(Kitagawa et al., 1996), while a C-terminal cluster starting with S386
and ending with S398 that also contains T390 and T394, presents a
consensus for GSK3β (Kim and Kimmel, 2000). Therefore, Cdk2 and
GSK3β are also primary candidates for marking Xenopus cyclin E for
MBT destruction by phosphorylation.
Finally, we show that cyclin E is ubiquitinated at the MBT and is
degraded by the proteasomal pathway. Proteasome inhibitors CLBL
and MG132 abolished cyclin E turnover after the MBT, resulting in
progressive increase of its cytoplasmic abundance. Unlike MG132,
CLBL treatment also prevented nuclear accumulation of cyclin E at
the MBT. Since we established that nuclear import is necessary for
cyclin E degradation, CLBL might be acting via this nonspeciﬁc but
relevant mechanism, rather than proteasome inhibition. Support for
75Y. Brandt et al. / Developmental Biology 355 (2011) 65–76this idea is provided by our observation that ubiquitination of
cyclin E at and after the MBT is abolished in CLBL injected embryos
(data not shown). This observation also suggests that cyclin E is
ubiquitinated in the nucleus, or that nuclear passage is necessary
for its ubiquitination. Cyclin E may ﬁrst be modiﬁed by phosphor-
ylation in the nucleus, similar to cyclin D1 (Alt et al., 2000), and
then ubiquitinated either in the nucleus or in the cytoplasm. Blocking
cyclin E nuclear export would allow us to test where ubiquitination
and subsequent degradation of Xenopus cyclin E take place. However,
unlike cyclin D1 or cyclin B1 (Hagting et al., 1998; Jackman et al., 2002)
export of cyclin E from the nucleus is independent of the nuclear
export receptor CRM-1 and is thus insensitive to the CRM-1 inhibitor
leptomycin B, which blocks nuclear export of these cyclins (Jackman
et al., 2002). Therefore resolution of these important questions
awaits the ability to prevent nuclear export of Xenopus cyclin E as
well as studies on the localization of Xenopus Cdc4 isoforms. Identiﬁca-
tion of the lysine residues that are ubiquitinatedwill also be addressed in
future experiments.
Why is cyclin E constitutively expressed in early embryos yet
restricted to the G1/S transition in the adult cell cycle? Cyclin E
functions in endoreplication in the placenta in mice (Geng et al.,
2003), while in Drosophila embryos a change in constitutive cyclin E
expression to G1/S phase expression mediates the transition from a
mitotic to anendoreplicative cell cycle (Knoblichet al., 1994;Richardson
et al., 1993). Constitutively expressed cyclin E in sea urchin embryos
functions in sperm maturation (Schnackenberg et al., 2007) and in
centrosome duplication (Schnackenberg et al., 2008), as does cyclin E in
mammalian cells, Xenopus extracts, and C. elegans embryos (Cowanand
Hyman, 2006; Hinchcliffe et al., 1999; Lacey et al., 1999; Matsumoto et
al., 1999). Both Drosophila and Xenopus embryos lack G phases when
cyclin E is constitutively present (Rempel et al., 1995; Richardson et al.,
1993), and acquire them when cyclin E is periodically expressed. In
mammalian ﬁbroblasts, constitutively overexpressing cyclin E shortens
G1 phase, leading to premature S phase entry (Ohtsubo and Roberts,
1993; Resnitzky et al., 1994). These data point to a requirement for
cyclin E periodicity to acquire and maintain a normal G1 phase.
Ubiquitination provides a rapid way of eliminating maternal cyclin E
whose constant presence throughout the cell cycle is no longer required
for pushing cells through the acceleratedmitotic divisions and therefore
serves a cell cycle remodeling function.
In normalmammalian cells, cyclin E–Cdk2 complexes are nuclear, as
are Cdc4 α and γ (van Drogen et al., 2006; Ye et al., 2004). In primary
breast tumors, cyclin E is often elevated in the cytoplasm (Shaye et al.,
2009). This altered localization has been suggested as a novel form of
deregulation on par with cyclin E overexpression. Furthermore, LMW
isoforms of cyclin E, but not full length cyclin E, are often localized to the
cytoplasm (Delk et al., 2009). These LMW isoforms induce high Cdk2
activity and are proposed to have ampliﬁed oncogenic activity via
aberrant protein–protein interactions and regulation due to their
altered localization (Delk et al., 2009). They are also less susceptible to
degradation mediated by Cdc4 nuclear subtypes α and γ. Further
elucidating the signals directingcyclin E into thenucleus fordegradation
may increase our understanding of how deregulation occurs in human
cancer cells, leading to a skewed nuclear to cytoplasmic distribution of
cyclin E. The regulation of spatial distribution is an important issue in
regard to orchestration of cyclin E degradation inXenopus development
and the relevance of its disruption to malignant transformation in
human cells.
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